Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial.
Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous...
Kakkar, Ajay K; Brenner, Benjamin; Dahl, Ola E; Eriksson, Bengt I; Mouret, Patrick; Muntz, Jim; Soglian, Andrea G; Pap, Akos F; Misselwitz, Frank; Haas, Sylvia; ,
2008-07-17 00:00:00
http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.pngThe LancetPubmedhttp://www.deepdyve.com/lp/pubmed/extended-duration-rivaroxaban-versus-short-term-enoxaparin-for-the-DViRW0I9DH
Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial.
Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial.
To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don’t already have one.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.